サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433610

合法大麻の市場規模、シェア、動向分析レポート：用途別、製品タイプ別、地域別、セグメント別予測、2024年～2030年

Legal Marijuana Market Size, Share & Trends Analysis Report By Application (Medical, Adult Use), By Product Type (Flower, Oils and Tinctures), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 125 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
合法大麻の市場規模、シェア、動向分析レポート：用途別、製品タイプ別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年01月18日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

合法大麻市場の成長と動向：

Grand View Research, Inc.の最新調査によると、世界の合法大麻市場規模は2030年までに1,022億4,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 25.7％で拡大すると予測されます。医療用および成人用/娯楽用大麻の合法化率の上昇、慢性疾患の治療へのこれらの製品の採用拡大、新製品発売数の増加が市場成長の主な要因です。例えば、2023年3月、ハーブサプリメント製剤メーカーであるアーウィン・ナチュラルズ社（Irwin Naturals Inc.）は、同社の新製品であるCBD 25mgソフトジェルをカナダで発売しました。同製品はStarseed Medicinal Medical Groupのプラットフォームを通じて全国で販売されています。

2022年4月、ニュージャージー州では娯楽用と医療用の大麻が合法化され、13の施設で販売されています。この動きにより、ニュージャージー州は嗜好用大麻が合法な米国18州の1つとなりました。大麻が広く受け入れられ、その需要が高いことから、市場は成長を遂げています。合法化以降、医療治療における大麻の使用が増加し、大麻の違法取引の減少につながっています。ニューヨーク大学の調査によると、50～64歳の大麻使用率は過去10年で倍増し、現在は9.0％に達しています。

また、合法大麻の価格は医療用大麻よりも安く、合法化後は大麻製品に税金が課されます。そのため、栽培者は非課税地域での栽培に力を入れています。例えば、ニューヨークでは、大麻栽培者は、政府から課税される税金から免除されるために、部族地域に集中しています。これにより、同州における大麻栽培の全体的なコストが下がり、栽培者は低価格で大麻を販売できるようになると期待されています。大麻の価格が下がることで、市場での大麻普及がさらに進むと予想されます。

合法大麻市場レポートハイライト

  • 用途別では、医療従事者や患者の間で薬用大麻の需要が高いことから、医療分野が2023年に79.1%の最大売上シェアを占めました。
  • 製品タイプ別では、花は他の製品に比べ低価格で入手が容易なため、オイルとチンキ剤が2023年に最大の市場シェアを占めました。
  • 2023年には、北米が市場全体の76.0%の売上シェアを占めました。これは、北米が大規模な消費者基盤を持つためであり、北米は医療用および娯楽用の大麻の使用を合法化した最初の地域のひとつです。

目次

第1章 合法大麻市場：調査手法と範囲

第2章 合法大麻市場：エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察

第3章 合法大麻市場： 変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
  • 合法大麻市場分析ツール

第4章 合法大麻市場：用途の推定・動向分析

  • 用途の市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 用途別の世界の合法大麻市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第5章 合法大麻市場：製品タイプの推定・動向分析

  • 製品タイプの市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 製品タイプ別の世界の合法大麻市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第6章 合法大麻市場：地域の推定・動向分析

  • 地域の市場シェア分析、2023年および2030年
  • 地域の市場ダッシュボード
  • 世界の地域市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年まで
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • オランダ
    • イタリア
    • スペイン
    • クロアチア
    • ポーランド
    • チェコ共和国
    • スイス
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • コロンビア
    • コロンビア
  • 中東・アフリカ
    • 南アフリカ
    • イサレル

第7章 競合情勢

  • 主要市場参入企業別の最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • Canopy Growth Corporation
    • AURORA CANNABIS INC.
    • Tilray Brands Inc.（Aphria, Inc.）
    • ABcann Medicinals, Inc.（VIVO Cannabis Inc.）
    • The Cronos Group
    • MARICANN INC.
    • Organigram Holdings Inc.
    • Lexaria Bioscience
    • GW Pharmaceuticals（Jazz Pharmaceuticals, Inc.）
    • Tikun Olam
    • United Cannabis Corporation
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 5 U.S. legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 7 Canada legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 9 Europe legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 12 Germany legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 14 UK legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 16 Netherlands legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 17 Netherlands legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 18 Italy legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 20 Spain legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 22 Croatia legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 23 Croatia legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 24 Poland legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 25 Poland legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 26 Czech Republic legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 27 Czech Republic legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 28 Switzerland legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 29 Switzerland legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 33 China legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 34 China legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 35 Japan legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 36 Japan legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 37 India legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 38 India legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 39 New Zealand legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 40 New Zealand legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 41 Australia legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 43 Thailand legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 44 Thailand legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 45 Latin America legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 46 Latin America legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 47 Latin America legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 48 Brazil legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 49 Brazil legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 50 Mexico legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 51 Mexico legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 52 Uruguay legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 53 Uruguay legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 54 Colombia legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 55 Colombia legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 56 MEA legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 57 MEA legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 58 MEA legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 59 South Africa legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Africa legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 61 Israel legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 62 Israel legal marijuana market, by product type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Legal marijuana market: market outlook
  • Fig. 9 Legal marijuana competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Legal marijuana market driver impact
  • Fig. 15 Legal marijuana market restraint impact
  • Fig. 16 Legal marijuana market strategic initiatives analysis
  • Fig. 17 Legal marijuana market: Application movement analysis
  • Fig. 18 Legal marijuana market: Application outlook and key takeaways
  • Fig. 19 Medical market estimates and forecast, 2018 - 2030
  • Fig. 20 Chronic Pain market estimates and forecast, 2018 - 2030
  • Fig. 21 Cryoablation market estimates and forecast, 2018 - 2030
  • Fig. 22 Cancer market estimates and forecast, 2018 - 2030
  • Fig. 23 Depression and Anxiety market estimates and forecast, 2018 - 2030
  • Fig. 24 Arthritis market estimates and forecast, 2018 - 2030
  • Fig. 25 Diabetes market estimates and forecast, 2018 - 2030
  • Fig. 26 Glaucoma market estimates and forecast, 2018 - 2030
  • Fig. 27 Migraines market estimates and forecast, 2018 - 2030
  • Fig. 28 Epilepsy market estimates and forecast, 2018 - 2030
  • Fig. 29 Multiple Sclerosis market estimates and forecast, 2018 - 2030
  • Fig. 30 AIDS market estimates and forecast, 2018 - 2030
  • Fig. 31 Amyotrophic Lateral Sclerosis market estimates and forecast, 2018 - 2030
  • Fig. 32 Post-traumatic Stress Disorder (PTSD) market estimates and forecast, 2018 - 2030
  • Fig. 33 Parkinson's market estimates and forecast, 2018 - 2030
  • Fig. 34 Tourette's market estimates and forecast, 2018 - 2030
  • Fig. 35 Others market estimates and forecast, 2018 - 2030
  • Fig. 36 Adult Use market estimates and forecast, 2018 - 2030
  • Fig. 37 Legal marijuana Market: Product Type movement Analysis
  • Fig. 38 Legal marijuana market: Product Type outlook and key takeaways
  • Fig. 39 Flower market estimates and forecasts, 2018 - 2030
  • Fig. 40 Oil and Tinctures market estimates and forecasts, 2018 - 2030
  • Fig. 41 Global Legal marijuana market: Regional movement analysis
  • Fig. 42 Global Legal marijuana market: Regional outlook and key takeaways
  • Fig. 43 Global Legal marijuana market share and leading players
  • Fig. 44 North America market share and leading players
  • Fig. 45 Europe market share and leading players
  • Fig. 46 Asia Pacific market share and leading players
  • Fig. 47 Latin America market share and leading players
  • Fig. 48 Middle East & Africa market share and leading players
  • Fig. 49 North America, by country
  • Fig. 50 North America
  • Fig. 51 North America market estimates and forecasts, 2018 - 2030
  • Fig. 52 U.S.
  • Fig. 53 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Canada
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe
  • Fig. 57 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 58 UK
  • Fig. 59 UK market estimates and forecasts, 2018 - 2030
  • Fig. 60 Germany
  • Fig. 61 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 62 Netherlands
  • Fig. 63 Netherlands market estimates and forecasts, 2018 - 2030
  • Fig. 64 Italy
  • Fig. 65 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 66 Spain
  • Fig. 67 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 68 Croatia
  • Fig. 69 Croatia market estimates and forecasts, 2018 - 2030
  • Fig. 70 Poland
  • Fig. 71 Poland market estimates and forecasts, 2018 - 2030
  • Fig. 72 Czech Republic
  • Fig. 73 Czech Republic market estimates and forecasts, 2018 - 2030
  • Fig. 74 Switzerland
  • Fig. 75 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 76 Asia Pacific
  • Fig. 77 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 78 China
  • Fig. 79 China market estimates and forecasts, 2018 - 2030
  • Fig. 80 Japan
  • Fig. 81 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 82 India
  • Fig. 83 India market estimates and forecasts, 2018 - 2030
  • Fig. 84 Thailand
  • Fig. 85 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 86 New Zealand
  • Fig. 87 New Zealand market estimates and forecasts, 2018 - 2030
  • Fig. 88 Australia
  • Fig. 89 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 90 Latin America
  • Fig. 91 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 92 Brazil
  • Fig. 93 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 94 Mexico
  • Fig. 95 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 96 Colombia
  • Fig. 97 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 98 Uruguay
  • Fig. 99 Uruguay market estimates and forecasts, 2018 - 2030
  • Fig. 100 Middle East and Africa
  • Fig. 101 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 104 Israel
  • Fig. 105 Israel Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 106 Market share of key market players- Legal marijuana market
目次
Product Code: GVR-2-68038-152-8

Legal Marijuana Market Growth & Trends:

The global legal marijuana market size is expected to reach USD 102.24 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 25.7% from 2024 to 2030. Increase in rate of legalization of marijuana for medicinal and adult-use/recreational marijuana, growing adoption of these products for the treatment of chronic ailments and rise in a number of new product launches are the primary factors responsible for the growth of the market. For instance, in March 2023, Irwin Naturals Inc., a herbal supplement formulator, introduced company's' new CBD 25mg Softgels in Canada. It is available through the Starseed Medicinal Medical Group platform across the nation.

In April 2022, New Jersey legalized recreational and medical marijuana, and it is being sold at 13 facilities. This move has made New Jersey one of the 18 states in the United States where recreational marijuana is legal. The market is experiencing growth due to the widespread acceptance of cannabis and its high demand. Since its legalization, the use of marijuana in medical treatments has increased, leading to a decrease in the illegal trade of cannabis. According to a study conducted by New York University, the usage of cannabis among individuals aged 50-64 has doubled in the last decade and has now reached 9.0%.

Moreover, price of legal marijuana is lower than medical marijuana, and taxes would be levied on marijuana products after its legalization. Therefore, cultivators are focusing on cultivating marijuana in areas that are exempt from taxes. For instance, in New York, marijuana cultivators are focusing on tribal regions to get exempted from the taxes levied by the government. This is expected to lower the overall cost of cultivation of marijuana in the state, and cultivators can sell marijuana at lower prices. Lower prices of marijuana are further anticipated to boost the adoption of marijuana in the market.

Legal Marijuana Market Report Highlights:

  • By application, medical segment accounted for the largest revenue share of 79.1% in 2023 owing to the high demand among healthcare practitioners and patients for medicinal marijuana.
  • By product type, oil and tinctures held the largest market share in 2023 owing to low price and ease of accessibility of flowers compared to other products.
  • In 2023, North America dominated the overall market with a revenue share of 76.0% owing to its large consumer base, North America was among the first regions to legalize the use of medical and recreational cannabis.

Table of Contents

Chapter 1. Legal Marijuana Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Product Type
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Legal Marijuana Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Product type outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Legal Marijuana Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
      • 3.2.1.2. Growing legalization of medical marijuana in various countries
      • 3.2.1.3. Elimination of black market through legalization of medical marijuana
      • 3.2.1.4. Impending legalization of marijuana for recreational/adult use
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lower market access of marijuana due to absence of legalization programs in several Asian and African countries
      • 3.2.2.2. Legalization of medical marijuana only for selected indications
      • 3.2.2.3. Supply shortage of medical marijuana in various countries
  • 3.3. Legal Marijuana Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Legal Marijuana Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Legal Marijuana Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Medical
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Cancer
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Chronic Pain
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Depression and Anxiety
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Arthritis
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.6. Diabetes
      • 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.7. Glaucoma
      • 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.8. Migraines
      • 4.4.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.9. Epilepsy
      • 4.4.1.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.10. Multiple Sclerosis
      • 4.4.1.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.11. AIDS
      • 4.4.1.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.12. Amyotrophic Lateral Sclerosis
      • 4.4.1.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.13. Alzheimer's
      • 4.4.1.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.14. Post-Traumatic Stress Disorder (PTSD)
      • 4.4.1.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.15. Parkinson's
      • 4.4.1.15.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.16. Tourette's
      • 4.4.1.16.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.17. Others
      • 4.4.1.17.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Adult Use
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Legal Marijuana Market: Product Type Estimates & Trend Analysis

  • 5.1. Product Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Legal Marijuana Market by Product Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Flower
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Oil and tinctures
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Legal Marijuana Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Netherlands
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Croatia
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Poland
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Czech Republic
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.9. Switzerland
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework/ reimbursement structure
      • 6.6.9.3. Competitive scenario
      • 6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. New Zealand
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Colombia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Colombia
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Isarel
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Canopy Growth Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. AURORA CANNABIS INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Tilray Brands Inc. (Aphria, Inc.)
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. ABcann Medicinals, Inc. (VIVO Cannabis Inc.)
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. The Cronos Group
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. MARICANN INC.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Organigram Holdings Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Lexaria Bioscience
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Tikun Olam
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. United Cannabis Corporation
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives